Recent studies with omigapil in rats with traumatic brain injury (TBI), which is the largest non-genetic-, non-aging-related risk factor for Alzheimer’s disease (AD), have shown that TCH346 reduces the level of high-level Tau protein and protects mice from neurodegeneration and AD [92]. This evidence concerns the gene MAPT and Alzheimer disease.